Oral antiplatelet drugs in patients with chronic kidney disease (CKD): a review.

about

In-hospital outcomes of transcatheter versus surgical aortic valve replacement in end stage renal disease.

P2860

Q48241320-EB8C1511-E840-4BC7-9A81-E0DA44464D51

P2860

Oral antiplatelet drugs in patients with chronic kidney disease (CKD): a review.

Item

http://www.wikidata.org/entity/Q39147420

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Oral antiplatelet drugs in patients with chronic kidney disease (CKD): a review.

@en

Oral antiplatelet drugs in patients with chronic kidney disease

@nl

type

Item

label

Oral antiplatelet drugs in patients with chronic kidney disease (CKD): a review.

@en

Oral antiplatelet drugs in patients with chronic kidney disease

@nl

prefLabel

Oral antiplatelet drugs in patients with chronic kidney disease (CKD): a review.

@en

Oral antiplatelet drugs in patients with chronic kidney disease

@nl

P1476

Oral antiplatelet drugs in patients with chronic kidney disease (CKD): a review

@en

P2093

Sunil V Rao

http://www.w3.org/2001/XMLSchema#string

P2860

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

Antithrombotic therapy in patients with chronic kidney disease

The mechanism of action of aspirin

Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease

Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction

Aspirin prescription and outcomes in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS)

2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

Prevalence of chronic kidney disease in the United States

P2888

s11239-017-1483-3

P304

519-527

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11239-017-1483-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Homam Ibrahim

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28229274

http://www.w3.org/2001/XMLSchema#string

Oral antiplatelet drugs in patients with chronic kidney disease (CKD): a review.

about

P2860

P2860

Oral antiplatelet drugs in patients with chronic kidney disease (CKD): a review.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698